When one of the most respected experts on Tobacco Harm Reduction (THR) in the world concludes that Australia's anti-vaping regulations are a 'policy failure,' it is urgent that the country's tobacco control methods are reviewed," said coordinator Nancy Loucas.
Nancy Loucas, the Executive Coordinator of the Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA), has said that the comprehensive review provides much-needed information for Australia's anti-vaping system, and offers some reasonable and sensible suggestions.
Before her comments, Dr. Colin Mendelsohn, an expert and physician in Australia, released a comprehensive 29-page report on Australia's prescription regulations solely for nicotine e-cigarettes. The report examined the progress made in the 12 months since the Therapeutic Goods Administration (TGA) introduced new regulations for nicotine e-liquid on October 1, 2021.
CAPHRA has stated that Australian leaders should rely less on the World Health Organization for advice and listen more to Dr. Mendelson, the scientific community, and the international community.
The Australian government has expanded their restricted prescription drug model and now customs officials are cracking down on individuals attempting to import nicotine e-cigarette liquid at the border. This regulation aims to prevent minors from being exposed to nicotine e-cigarettes while allowing adult smokers to use them as a tool to quit smoking.
Australia is the only Western democracy that requires a prescription for nicotine e-cigarettes, a policy that is not only outrageous but also a complete failure in terms of public health. This comprehensive review provides much-needed information on Australia's anti-vaping regime, and offers some sensible and reasonable suggestions, according to Ms. Loucas.
Dr. Mendelsohn's conclusion is that the regulations in Australia have failed to achieve their intended goals. In fact, they have had the opposite effect. The thriving black market has grown, there has been a sharp increase in teenage use of electronic cigarettes, enforcement against illegal sales and imports is ineffective, very few doctors prescribe nicotine, and very few pharmacies distribute nicotine e-liquids.
Obtaining electronic cigarette products has become increasingly difficult and expensive for adult smokers. As a result, most Australian electronic cigarette users purchase unregulated supplies on the black market and illegally import them without a prescription. Currently, it is easier to purchase deadly cigarettes from over 20,000 retail stores than to access safer alternatives.
CAPHRA states that in terms of effectively controlling tobacco, Australia continues to lag behind in the Asia-Pacific region, and is falling further behind.
According to the statement, approximately 70 countries worldwide have regulated safer nicotine products, however, Australia continues to prohibit adult retail. The medicalization will only make it harder for Australian smokers to switch to e-cigarettes and make it nearly impossible for Australia to achieve its goal of reducing smoking rates by 10%, the spokesperson stated.
The report's main recommendation is to allow sales in licensed retail stores, with strict enforcement of age verification and penalties, including license revocation, for selling to minors. Nicotine liquids with concentrations below 6% should be exempt from federal or state-level poison standards for harm reduction. Furthermore, the system should be overseen by the Australian Competition and Consumer Commission.
The Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA) has stated that politicians and health officials in Australia should take heed of the opinions of Dr. Mendelsohn, the scientific community and the international society, instead of solely relying on the World Health Organization's (WHO) viewpoint.
The overall smoking rates in Australia have remained relatively stable in recent years, whereas New Zealand has seen a 50% reduction in smoking rates over the past decade. New Zealand is promoting the use of e-cigarettes as an effective tool for quitting smoking, while Australia's "quit smoking or die" tobacco control approach has failed its 2.3 million smokers, according to Ms. Loucas.
Despite 20,000 Australian smokers dying prematurely due to smoking-related illnesses, Australia's anti-e-cigarette policy has failed and needs to double down on efforts.
CAPHRA has expressed outrage at the active discouragement of Australian adult smokers to switch to less harmful nicotine alternatives. Queensland, New South Wales, and Western Australia continue to invest significant amounts of public funds into a misleading anti-vaping campaign.
Statement:
This article was compiled from third-party information and is only for industry communication and learning purposes.
This article does not reflect the views of 2FIRSTS and 2FIRSTS cannot confirm the truthfulness and accuracy of the article's content. The translation of this article is intended only for industry communication and research purposes.
Due to limitations in translation ability, the translated article may not fully express the same meaning as the original. Please refer to the original text for accuracy.
2FIRSTS maintains complete alignment with the Chinese government when it comes to any domestic, Hong Kong, Macao, Taiwan, or foreign-related expressions and positions.
The copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
